Genetics of bipolar disorder

Application of Clinical Genetics

Volumn 7, Issue , 2014, Pages 33-42

  Kerner, Berit ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bipolar disorder; Genetic testing; Genomic variants; Mendelian disorders; Risk factors; Structural variants

Indexed keywords

CALCIUM CHANNEL L TYPE; MEMBRANE PROTEIN; NEUROCAN; PROTEIN CACNA1C; PROTEIN ODZ4; UNCLASSIFIED DRUG;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BIPOLAR DISORDER; CACNA1C GENE; CHROMOSOME 10Q; CHROMOSOME 10Q26; CHROMOSOME 15Q; CHROMOSOME 15Q11; CHROMOSOME 15Q13.3; CHROMOSOME 17P; CHROMOSOME 17P11.2; CHROMOSOME 22Q; CHROMOSOME 22Q11; CHROMOSOME DELETION 22Q11; CHROMOSOME DISORDER; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; IMPULSE CONTROL DISORDER; INTELLECTUAL IMPAIRMENT; MENTAL DISEASE; MONOGENIC DISORDER; MOOD DISORDER; NCAN GENE; NONHUMAN; ODZ4 GENE; PRADER WILLI SYNDROME; PSYCHOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMITH MAGENIS SYNDROME; VELOCARDIOFACIAL SYNDROME;

EID: 84896719748     PISSN: None     EISSN: 1178704X     Source Type: Journal    
DOI: 10.2147/TACG.S39297     Document Type: Review

References (105)

1. National Institute of Mental Health. Bipolar disorder among adults. Available from: http://www.nimh.nih.gov/statistics/1bipolar_adult.shtml. Accessed January 10, 2014.
2. American Psychiatric Association [homepage on the internet]. Available from: http://www.psychiatry.org/home. Accessed January 10, 2014.
3. Merikangas KR, Cui L, Heaton L, et al. Independence of familial transmission of mania and depression: results of the NIMH family study of affective spectrum disorders. Mol Psychiatry. Epub October 15, 2013.
4. Vandeleur CL, Merikangas KR, Strippoli MP, Castelao E, Preisig M. Specificity of psychosis, mania and major depression in a contemporary family study. Mol Psychiatry. Epub October 15, 2013.
5. Corry J, Green M, Roberts G, et al. Anxiety, stress and perfectionism in bipolar disorder. J Affect Disord. 2013;151(3):1016-1024.
6. van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, et al. Psychiatric comorbidity in treatment seeking substance use disorder patients with and without ADHD; results of the IASP study. Addiction. Epub October 4, 2013.
7. Di Florio A, Craddock N, van den Bree M. Alcohol misuse in bipolar disorder. A systematic review and meta-analysis of comorbidity rates. Eur Psychiatry. Epub September 25, 2013.
8. Di Nicola M, Sala L, Romo L, et al. Adult attention-deficit/hyperactivity disorder in major depressed and bipolar subjects: role of personality traits and clinical implications. Eur Arch Psychiatry Clin Neurosci. Epub September 28, 2013.
9. Leboyer M, Kupfer DJ. Bipolar disorder: new perspectives in health care and prevention. J Clin Psychiatry. 2010;71(12):1689-1695.
10. Fagiolini A, Kupfer DJ, Rucci P, Scott JA, Novick DM, Frank E. Suicide attempts and ideation in patients with bipolar I disorder. J Clin Psychiatry. 2004;65(4):509-514.
11. Hauser M, Galling B, Correll CU. Suicidal ideation and suicide attempts in children and adolescents with bipolar disorder: a systematic review of prevalence and incidence rates, correlates, and targeted interventions. Bipolar Disord. 2013;15(5):507-523.
12. Post RM, Leverich GS, Kupka RW, et al. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry. 2010;71(7):864-872.
13. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet. 2003;123C(1):48-58.
14. Wray NR, Gottesman II. Using summary data from the Danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder. Front Genet. 2012;3:118.
15. Aas M, Etain B, Bellivier F, et al. Additive effects of childhood abuse and cannabis abuse on clinical expressions of bipolar disorders. Psychol Med. Epub September 13, 2013.
16. Brown AS. The environment and susceptibility to schizophrenia. Prog Neurobiol. 2011;93(1):23-58.
17. Meli G, Ottl B, Paladini A, Cataldi L. Prenatal and perinatal risk factors of schizophrenia. J Matern Fetal Neonatal Med. 2012;25(12): 2559-2563.
18. Canetta SE, Brown AS. Prenatal infection, maternal immune activation, and risk for schizophrenia. Transl Neurosci. 2012;3(4):320-327.
19. Khandaker GM, Zimbron J, Lewis G, Jones PB. Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol Med. 2013;43(2): 239-257.
20. Haukvik UK, McNeil T, Lange EH, et al. Pre- and perinatal hypoxia associated with hippocampus/amygdala volume in bipolar disorder. Psychol Med. 2013;27:1-11.
21. Kenny EM, Cormican P, Furlong S, et al. Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders. Mol Psychiatry. Epub October 15, 2013.
22. Craddock N, Sklar P. Genetics of bipolar disorder. Lancet. 2013;381(9878):1654-1662.
23. Szczepankiewicz A. Evidence for single nucleotide polymorphisms and their association with bipolar disorder. Neuropsychiatr Dis Treat. 2013;9:1573-1582.
24. Sklar P, Smoller JW, Fan J, et al. Whole-genome association study of bipolar disorder. Mol Psychiatry. 2008;13(6):558-569.
25. Ferreira MA, O'Donovan MC, Meng YA, et al. Wellcome Trust Case Control Consortium. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 2008;40(9):1056-1058.
26. Moskvina V, Craddock N, Holmans P, et al. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry. 2009;14(3):252-260.
27. Kloiber S, Czamara D, Karbalai N, et al. ANK3 and CACNA1C: missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples. J Psychiatr Res. 2012;46(8):973-979.
28. Zhang J, Cai J, Zhang X, et al. Does the bipolar disorder-associated CACNA1C gene confer susceptibility to schizophrenia in Han Chinese? J Mol Neurosci. 2013;51(2):474-477.
29. Zhang X, Zhang C, Wu Z, et al. Association of genetic variation in CACNA1C with bipolar disorder in Han Chinese. J Affect Disord. 2013;150(2):261-265.
30. Gershon ES, Grennan K, Busnello J, et al. A rare mutation of CACNA1C in a patient with bipolar disorder, and decreased gene expression associated with a bipolar-associated common SNP of CACNA1C in brain. Mol Psychiatry. Epub August 27, 2013.
31. Bigos KL, Mattay VS, Callicott JH, et al. Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch Gen Psychiatry. 2010;67(9):939-945.
32. Wang F, McIntosh AM, He Y, Gelernter J, Blumberg HP. The association of genetic variation in CACNA1C with structure and function of a frontotemporal system. Bipolar Disord. 2011;13(7-8):696-700.
33. Soeiro-de-Souza MG, Otaduy MC, Dias CZ, Bio DS, Machado-Vieira R, Moreno RA. The impact of the CACNA1C risk allele on limbic structures and facial emotions recognition in bipolar disorder subjects and healthy controls. J Affect Disord. 2012;141(1):94-101.
34. Soeiro-de-Souza MG, Bio DS, Dias VV, Vieta E, Machado-Vieira R, Moreno RA. The CACNA1C risk allele selectively impacts on executive function in bipolar type I disorder. Acta Psychiatr Scand. 2013;128(5):362-369.
35. Zhang Q, Shen Q, Xu Z, et al. The effects of CACNA1C gene polymorphism on spatial working memory in both healthy controls and patients with schizophrenia or bipolar disorder. Neuropsychopharmacology. 2012;37(3):677-684.
36. Paulus FM, Bedenbender J, Krach S, et al. Association of rs1006737 in CACNA1C with alterations in prefrontal activation and fronto-hippocampal connectivity. Hum Brain Mapp. Epub February 13, 2013.
37. Cross-Disorder Group of the Psychiatric Genomics Consortium, Smoller JW, Craddock N, et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381(9875):1371-1379.
38. Green EK, Hamshere M, Forty L, et al. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Mol Psychiatry. 2013;18(12):1302-1307.
39. Hamshere ML, Walters JT, Smith R, et al. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry. 2013;18(6):708-712.
40. Splawski I, Timothy KW, Sharpe LM, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119(1):19-31.
41. Hsiao PY, Tien HC, Lo CP, Juang JM, Wang YH, Sung RJ. Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies. Appl Clin Genet. 2013;6:1-13.
42. Boczek NJ, Best JM, Tester DJ, et al. Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndrome. Circ Cardiovasc Genet. 2013;6(3):279-289.
43. Brugada J, Brugada P. Further characterization of the syndrome of right bundle branch block, ST segment elevation, and sudden cardiac death. J Cardiovasc Electrophysiol. 1997;8(3):325-331.
44. Dao DT, Mahon PB, Cai X, et al. Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. Biol Psychiatry. 2010;68(9):801-810.
45. PubMed [homepage on the internet]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/. Accessed January 10, 2014.
46. Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. 2011;43(10): 977-983.
47. Tesli M, Egeland R, Sønderby IE, et al. No evidence for association between bipolar disorder risk gene variants and brain structural phenotypes. J Affect Disord. 2013;151(1):291-297.
48. Heinrich A, Lourdusamy A, Tzschoppe J, et al. The risk variant in ODZ4 for bipolar disorder impacts on amygdala activation during reward processing. Bipolar Disord. Epub April 24, 2013.
49. Tesli M, Skatun KC, Ousdal OT, et al. CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls. PLoS One. 2013;8(2):e56970.
50. Krug A, Witt SH, Backes H, et al. A genome-wide supported variant in CACNA1C influences hippocampal activation during episodic memory encoding and retrieval. Eur Arch Psychiatry Clin Neurosci. Epub July 17, 2013.
51. Ben-Zur T, Feige E, Motro B, Wides R. The mammalian Odz gene family: homologs of a Drosophila pair-rule gene with expression implying distinct yet overlapping developmental roles. Dev Biol. 2000;217(1): 107-120.
52. Zhou XH, Brandau O, Feng K, et al. The murine Ten-m/Odz genes show distinct but overlapping expression patterns during development and in adult brain. Gene Expr Patterns. 2003;3(4):397-405.
53. Suzuki N, Fukushi M, Kosaki K, et al. Teneurin-4 is a novel regulator of oligodendrocyte differentiation and myelination of small-diameter axons in the CNS. J Neurosci. 2012;32(34):11586-11599.
54. Cichon S, Mühleisen TW, Degenhardt FA, et al. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet. 2011;88(3):372-381.
55. Oruč L, Kapur-Pojskić L, Ramić J, Pojskić N, Bajrović K. Assessment of relatedness between neurocan gene as bipolar disorder susceptibility locus and schizophrenia. Bosn J Basic Med Sci. 2012;12(4):245-248.
56. Mühleisen TW, Mattheisen M, Strohmaier J, et al. Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder. Schizophr Res. 2012;138(1):69-73.
57. Schultz CC, Mühleisen TW, Nenadic I, et al. Common variation in NCAN, a risk factor for bipolar disorder and schizophrenia, influences local cortical folding in schizophrenia. Psychol Med. Epub June 24, 2013.
58. Zhou XH, Brakebusch C, Matthies H, et al. Neurocan is dispensable for brain development. Mol Cell Biol. 2001;21(17):5970-5978.
59. Rauch U, Zhou XH, Roos G. Extracellular matrix alterations in brains lacking four of its components. Biochem Biophys Res Commun. 2005;328(2):608-617.
60. Lu Y, Feskens EJ, Boer JM, et al. Exploring genetic determinants of plasma total cholesterol levels and their predictive value in a longitudinal study. Atherosclerosis. 2010;213(1):200-205.
61. Yan TT, Yin RX, Li Q, et al. Sex-specific association of rs16996148 SNP in the NCAN/CILP2/PBX4 and serum lipid levels in the Mulao and Han populations. Lipids Health Dis. 2011;10:248.
62. Zhou L, Ding H, Zhang X, et al. Genetic variants at newly identified lipid loci are associated with coronary heart disease in a Chinese Han population. PLoS One. 2011;6(11):e27481.
63. Speliotes EK, Yerges-Armstrong LM, Wu J, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011;7(3):e1001324.
64. Gorden A, Yang R, Yerges-Armstrong LM, et al. Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity. Hum Hered. 2013;75(1): 34-43.
65. Nakayama K, Bayasgalan T, Yamanaka K, et al. Large scale replication analysis of loci associated with lipid concentrations in a Japanese population. J Med Genet. 2009;46(6):370-374.
66. Online Mendelian Inheritance in Man (OMIM) [homepage on the internet]. Available from: http://www.ncbi.nlm.nih.gov/omim. Accessed January 10, 2014.
67. Boer H, Holland A, Whittington J, Butler J, Webb T, Clarke D. Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet. 2002;359(9301):135-136.
68. Burnside RD, Pasion R, Mikhail FM, et al. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet. 2011;130(4):517-528.
69. Skokauskas N, Sweeny E, Meehan J, Gallagher L. Mental health problems in children with Prader-Willi syndrome. J Can Acad Child Adolesc Psychiatry. 2012;21(3):194-203.
70. Fan Z, Greenwood R, Fisher A, Pendyal S, Powell CM. Characteristics and frequency of seizure disorder in 56 patients with Prader-Willi syndrome. Am J Med Genet A. 2009;149A(7):1581-1584.
71. Sutcliffe JS, Nakao M, Christian S, et al. Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat Genet. 1994;8(1):52-58.
72. Hall BD, Smith DW. Prader-Willi syndrome. A resumé of 32 cases including an instance of affected first cousins, one of whom is of normal stature and intelligence. J Pediatr. 1972;81(2):286-293.
73. Autio S, Pihko H, Tengström C. Clinical features in a de novo interstitial deletion 15q13 to q15. Clin Genet. 1988;34(5):293-298.
74. Ninomiya S, Yokoyama Y, Kawakami M, Une T, Maruyama H, Morishima T. Unique maternal deletion of 15q in a patient with some symptoms of Prader-Willi syndrome. Pediatr Int. 2005;47(5):541-545.
75. Sharp AJ, Mefford HC, Li K, et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet. 2008;40(3):322-328.
76. Helbig I, Mefford HC, Sharp AJ, et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet. 2009;41(2):160-162.
77. de Kovel CG, Trucks H, Helbig I, et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain. 2010;133(Pt 1):23-32.
78. van Bon BW, Mefford HC, Menten B, et al. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet. 2009;46(8):511-523.
79. Miller DT, Shen Y, Weiss LA, et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet. 2009;46(4):242-248.
80. Pagnamenta AT, Wing K, Sadighi Akha E, et al. A 15q13.3 microdeletion segregating with autism. Eur J Hum Genet. 2009;17(5):687-692.
81. Ben-Shachar S, Lanpher B, German JR, et al. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J Med Genet. 2009;46(6):382-388.
82. Sahoo T, Theisen A, Rosenfeld JA, et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet Med. 2011;13(10):868-880.
83. Shinawi M, Schaaf CP, Bhatt SS, et al. A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet. 2009;41(12):1269-1271.
84. Hoppman-Chaney N, Wain K, Seger PR, Superneau DW, Hodge JC. Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype. Clin Genet. 2013;83(4):345-351.
85. Endris V, Hackmann K, Neuhann TM, et al. Homozygous loss of CHRNA7 on chromosome 15q13.3 causes severe encephalopathy with seizures and hypotonia. Am J Med Genet A. 2010;152A(11):2908-2911.
86. GeneReviews™ [internet]. Edited by Roberta A Pagon, Editor-in-chief, Margaret P Adam, Thomas D Bird, Cynthia R Dolan, Chin-To Fong, Richard JH Smith, and Karen Stephens. Seattle (WA): University of Washington, Seattle; 1993-2014. Available from http://www.ncbi.nlm.nih.gov/books/. Accessed October 18, 2013.
87. Mehta L, Duckett DP, Young ID. Behaviour disorder in monosomy 10qter. J Med Genet. 1987;24(3):185-186.
88. Courtens W, Wuyts W, Rooms L, Pera SB, Wauters J. A subterminal deletion of the long arm of chromosome 10: a clinical report and review. Am J Med Genet A. 2006;140(4):402-409.
89. Miller ND, Nance MA, Wohler ES, et al. Molecular (SNP) analyses of overlapping hemizygous deletions of 10q25.3 to 10qter in four patients: evidence for HMX2 and HMX3 as candidate genes in hearing and vestibular function. Am J Med Genet A. 2009;149A(4):669-680.
90. Yatsenko SA, Kruer MC, Bader PI, et al. Identification of critical regions for clinical features of distal 10q deletion syndrome. Clin Genet. 2009;76(1):54-62.
91. Irving M, Hanson H, Turnpenny P, et al. Deletion of the distal long arm of chromosome 10; is there a characteristic phenotype? A report of 15 de novo and familial cases. Am J Med Genet A. 2003;123A(2):153-163.
92. Bassett AS, Chow EW, Husted J, et al. Clinical features of 78 adults with 22q11 deletion syndrome. Am J Med Genet A. 2005;138(4):307-313.
93. McLean SD, Saal HM, Spinner NB, Emanuel BS, Driscoll DA. Velo-cardio-facial syndrome. Intrafamilial variability of the phenotype. Am J Dis Child. 1993;147(11):1212-1216.
94. Jolin EM, Weller RA, Weller EB. Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11.2 deletion syndrome. J Affect Disord. 2012;136(3):222-228.
95. Aneja A, Fremont WP, Antshel KM, et al. Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome). J Child Adolesc Psychopharmacol. 2007;17(1):105-114.
96. Shprintzen RJ, Goldberg RB, Young D, Wolford L. The velo-cardio-facial syndrome: a clinical and genetic analysis. Pediatrics. 1981;67(2):167-172.
97. Shprintzen RJ. Velo-cardio-facial syndrome: 30 Years of study. Dev Disabil Res Rev. 2008;14(1):3-10.
98. Evers LJ, Vermaak MP, Engelen JJ, Curfs LM. The velocardiofacial syndrome in older age: dementia and autistic features. Genet Couns. 2006;17(3):333-340.
99. Butcher NJ, Chow EW, Costain G, Karas D, Ho A, Bassett AS. Functional outcomes of adults with 22q11.2 deletion syndrome. Genet Med. 2012;14(10):836-843.
100. De Leersnyder H. Smith-Magenis syndrome. Handb Clin Neurol. 2013;111:295-2966.
101. Girirajan S, Elsas LJ 2nd, Devriendt K, Elsea SH. RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions. J Med Genet. 2005;42(11):820-828.
102. Elsea SH, Williams SR. Smith-Magenis syndrome: haploinsufficiency of RAI1 results in altered gene regulation in neurological and metabolic pathways. Expert Rev Mol Med. 2011;13:e14.
103. Juyal RC, Figuera LE, Hauge X, et al. Molecular analyses of 17p11.2 deletion in 62 Smith-Magenis syndrome patients. Am J Med Genet. 1996;58:998-1007.
104. Gershon ES, Alliey-Rodriguez N. New ethical issues for genetic counseling in common mental disorders. Am J Psychiatry. 2013;170(9): 968-976.
105. Wilfond BS, Thomson EJ. Models of public health genetic policy development. In: Khoury MJ, Burke W, Thomson EJ, editors. Genetics and Public Health in the 21th Century. Oxford, UK: Oxford University Press; 2000:61-81.